Polycystic ovary syndrome is no longer called polycystic ovary syndrome. A landmark consensus study in The Lancet, built on 22,000 clinicians and patients across 11 years of global consultation, has renamed the condition polyendocrine metabolic ovarian syndrome, or PMOS. The cysts were never the story. The metabolism was. The hormones were. The gut was.

In our 100th episode, Nico Misleh, MSN, FNP-C breaks down what the rename actually means. Why the old name pointed providers toward the wrong organ and the wrong mechanism. Why so many women with every sign of the condition were told they did not have it because their ovaries looked clear. And why the framework HRT University has taught from the start, relative estrogen dominance layered on sluggish detoxification, gut-driven estrogen recycling, compromised thyroid, and a metabolic engine forced into glycolysis, is the same physiology the new name finally reflects.

If you have been treating PCOS the way you were taught and something never sat right, this episode is the reframe. The name changed. The mechanism did not.

The HRT University Master Course is jointly accredited through Pinnacle Conference, LLC (ACCME, ACPE, ANCC). Earn 30 CE hours, including 12 hours of pharmacology.

Master Course: https://bit.ly/4twBb0D

Nico's weekly clinical email: https://nicomislehnp.kit.com/8050eeea5f

Provider community: https://www.facebook.com/groups/1179376819949373/